Thrombin generation in children with acute lymphoblastic leukemia: Effect of leukemia immunophenotypic subgroups

Pediatric Hematology and Oncology

Volumn 17, Issue 8, 2000, Pages 667-672

  Giordano, P ^a   Del Vecchio, G C ^a   Santoro, N ^a   Arcamone, G ^a   Coppola, B ^a   Altomare, M ^a   Schettini, F ^a   Iolascon, A ^a   De Mattia, D ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

ALL; Children; Immunophenotype; Thrombotic risk

Indexed keywords

ASPARAGINASE; CANCER PROCOAGULANT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLOOD CLOTTING; CANCER CHEMOTHERAPY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; IMMUNOPHENOTYPING; MALE; RISK FACTOR; THROMBIN TIME; THROMBOSIS;

EID: 0033652859     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/08880010050211376     Document Type: Article

References (25)

1. The coagulopathy of childhood leukemia
2. Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: Risk of thrombotic complications in L-asparaginase induced antithrombin III deficiency
3. Tissue factor activity of normal and neoplastic cells: Quantitation and species specifity
4. Isolation and characterization of cancer procoagulant: A cysteine proteinase from malignant tissue
5. Different expression of procoagulant activity in macrophages associated with experimental and human tumors
6. Increased production of mononuclear cell procoagulant activity in Hodgkin's disease
7. Characterization of the platelet-aggregation activity of tumors cells
8. Effect of interferon alpha, interferon gamma and tumor necrosis factor on the procoagulant activity of human cancer cells
9. Inherited trombophilia: Pathogenesis, clinical syndromes and management
10. Alterations of hemostasis associated with malignancy: Etiology, pathophysiology, diagnosis and management
11. Thrombosis in children receiving asparaginase: Determining patients at risk
12. Coagulation and platelet abnormalities in patients with cancer
13. Mutation in blood coagulation factor V associated with resistance to activated protein V
14. A candidate genetic risk factor for vascular disease: A common mutation in methylene tetrahydrofolate reductase
15. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and increase in venous thrombosis
16. A polymorphism of a platelet glycoprotein receptor as an inherithed risk factor for coronary thrombosis
17. Modified APG-resistance test offers increased sensitivity and specificity for the FV:Q506 allele
18. Effect of L-asparaginase administration on coagulation and platelet function in children with leukemia
19. Changes in coagulation and fibrinolysis in childhhod acute lymphoblastic leukemia re-induction therapy using three different asparaginase preparations
20. L'equilibrio emostatico durante la fase di induzione in bambini affetti da leucemia linfatica acuta: Effetti della L-Asparaginasi
21. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors
22. Tumor necrosis factoralfa (TNF alfa) and thrombin generation in children with acute lymphoblastic leukemia (ALL)
23. Modulation of endothelial hemostatic porperties by TNF
24. Fibrinolytic pathways and the endothelium
25. Activation of coagulation after administration of tumor necrosis factor to normal subjects